2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YS; Ho, IK; Hsu, YT; Kuo, HW; Liu, SW; Liu, YL; Tsou, HH; Wang, SC; Wu, SL | 1 |
1 other study(ies) available for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Hepatitis C virus infection influences the S-methadone metabolite plasma concentration.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Cell Line, Transformed; Cytochrome P-450 CYP2B6; Demography; Dose-Response Relationship, Drug; Female; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Male; Methadone; Multivariate Analysis; Pyrrolidines; Regression Analysis | 2013 |